Director Share Transactions
UK Companies Report Multiple Director Share Dealings Under Market Abuse Rules
Anonymous
Key Points
1
IntegraFin said the notification was received on 22 September 2026 and that the purchases were made by the trustee of the IntegraFin Share Incentive Plan 2018 through market purchases, rather than directly by the directors or PDMRs.
2
Coca-Cola Europacific Partners disclosures specified fractional acquisitions under two employee schemes: 3.633030 ordinary shares under the UK Share Plan and 7.980050 shares under the UK Shareshop; another disclosed acquisition involved 3.633030 shares under the Share Plan and 1.994980 under the Shareshop.
3
The Intercede transaction took place on 22 September 2026, when Non-Executive Director Dan O’Brien bought the 22,070 shares in the cybersecurity software company at £1.20 each.
4
Staffline described the 23,391-share sale and purchase by Henry Spain Investment Services as offsetting transactions, leaving its notifiable interest unchanged at 34,778,675 shares and its ownership unchanged at 29.98% of the issued share capital.
London-listed companies filed a wave of director share transactions this week under market-abuse reporting rules. The deals ranged from small purchases by executives to major transfers involving associates of board members. Trading View documented the filings across sectors including financial services, pharmaceuticals, and investment trusts.
Smaller Stakes and Scrip Dividends at Mid-Cap Firms
Tekmar's Managing Director Fraser Gibson sold 250,061 shares at 14 pence each, cutting his stake but retaining 205,798 shares (0.147% of the company). At Volex, two directors received scrip-dividend shares: Lord Rothschild now holds 26.14% and Dave Webster holds 0.084%. These transactions reflect routine executive portfolio adjustments and dividend reinvestment.
Major Associate Stakes at Investment Trust
North Atlantic Smaller Companies Investment Trust disclosed that associates of Non-Executive Director Peregrine Moncreiffe increased their combined holding to 4,492,962 shares, or 3.594% of the trust. This represents a significant concentration of voting power tied to a board member's network. Trading View noted the filing showed a meaningful shift in the shareholder base.
Family Transfers and Share Scheme Acquisitions
Fuller, Smith & Turner reported two separate moves: an associate of Non-Executive Director Richard Fuller made share gifts, and Chief Operating Officer Frederick Turner transferred shares to his spouse. At IntegraFin, the trustee of the company's Share Incentive Plan bought shares for directors and PDMRs at £3.71 each on 22 September 2026, according to Trading View. These were market purchases rather than direct executive buys.
Coca-Cola Europacific Partners employees acquired fractional shares through two schemes: the UK Share Plan and the UK Shareshop. One disclosure showed 3.633030 shares under the Share Plan and 7.980050 under the Shareshop. Hikma Pharmaceuticals also reported employee-plan acquisitions tied to dividend reinvestment and stock-purchase programs.
Offsets and Individual Buys Across Sectors
Staffline Chairman Thomas Spain's associated entity, Henry Spain Investment Services, sold and bought 23,391 shares at roughly £0.40 each. The two offsetting trades left the holding unchanged at 34,778,675 shares (29.98% of issued capital). Intercede's Non-Executive Director Dan O'Brien took a different approach, buying 22,070 shares at £1.20 each on 22 September 2026, raising his stake to 75,714 shares (0.124%). Trading View also noted separate deals at China Pacific Insurance, Coca-Cola HBC, and GSK, though full details were not disclosed.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
21
Articles
11
Reach
32
Topics
A
AnonymousAuthor
